Disease Vs
Disease Vs
Podcast Description
Disease Vs is all about diving into the biggest battles in modern science — from cancer to antibiotic resistance — and uncover how breakthroughs in biomedical research are reshaping how we treat diseases and deal with global heath challenges!
Podcast Insights
Content Themes
The podcast covers a wide array of topics related to disease management and scientific advancements, with specific themes including cancer treatments, antibiotic resistance, female infertility, and multiple sclerosis therapies. Examples of episodes include examinations of targeted vs. non-targeted cancer therapies, the implications of age-related female infertility interventions, and the impact of monoclonal antibodies on multiple sclerosis treatment.
Disease Vs is all about diving into the biggest battles in modern science — from cancer to antibiotic resistance — and uncover how breakthroughs in biomedical research are reshaping how we treat diseases and deal with global heath challenges!
Join, Joel, Linka & Govind as they explore the causes of age-related female infertility, and where in this process interventions can occur. After the age of 35, female fertility starts to decline rapidly. The team discuss possible nutritional and pharmacological approaches to slow fertility decline before ending on a discussion about fertility intervention strategies (such as IVF).
References:
[1] Karayiannis, D., Kontogianni, M.D., Mendorou, C., Mastrominas, M., and Yiannakouris, N. (2018). Adherence to the Mediterranean diet and IVF success rate among non-obese women attempting fertility. Human Reproduction, 33(3), 494-502
[2] Baroutis, D., Kalampokas, T., Katsianou, E., Psarris, A., Daskalakis, G., Panoulis, K. et al. (2024). The Role of the Mediterranean Diet in Assisted Reproduction: A Literature Review. Nutrients, 16(16), 2807.
[3] Ruder, E.H., Hartman, T.J., Blumberg, J., and Goldman, M.B. (2008). Oxidative stress and antioxidants: exposure and impact on female fertility. Human Reproduction Update, 14(4), 345-357.
[4] Kabodmehri, R., Javaheri, F.S.H, Alami, F., Mahmoudi, Z., Amjadi, A., Saeedirad, Z. et al. (2023). Female infertility and dietary antioxidant index (DAI): a case-control study. BMC Women’s Health, 608.
[5] Luddi, A., Capaldo, A., Focarelli, R., Gori, M., Morgante, G., Piomboni, P. et al. (2016). Antioxidants reduce oxidative stress in follicular fluid of aged women undergoing IVF. Reproductive Biology and Endocrinology, 14.
References For Part 2: Pharmacological Interventions:
[6] Liu, M., Yin, Y., Ye, X., Zeng, M., Zhao, Q., Keefe, D.L., et al. (2013). Resveratrol protects against age-associated infertility in mice. Human Reproduction, 28(3), 707–17.
[7] Sasaki, H., Hamatani, T., Kamijo, S., Iwai, M., Kobanawa, M., Ogawa, S. et al. (2019). Impact of Oxidative Stress on Age-Associated Decline in Oocyte Developmental Competence. Frontiers in Endocrinology. 22;10, 811.
[8] Wang, L., Tang, J., Wang, L., Tan, F., Song, H., Zhou, J., et al. (2021). Oxidative stress in oocyte aging and female reproduction. Journal of Cellular Physiology. 236(12), 7966–83.
[9] Dou, X., Sun, Y., Li, J., Zhang, J., Hao, D., Liu, W., et al. (2017). Short‐term rapamycin treatment increases ovarian lifespan in young and middle‐aged female mice. Aging Cell. 16(4), 825–36.
[10] Guo, Z., Yu, Q. (2019). Role of mTOR Signaling in female reproduction. Frontiers in Endocrinology. Oct 9, 10:692.
[11] Goldman, K.N,., Chenette, D., Arju, R., Duncan, F.E., Keefe, D.L., Grifo, J.A. et al. (2017). mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy. Proceedings of the National Academy of Sciences of the United States of America. 21;114(12), 3186–91.
[12] Fan, J., Chen, C., Zhong, Y. (2024). A cohort study on IVF outcomes in infertile endometriosis patients: the effects of rapamycin treatment. Reproductive Biomedicine Online. 48(1), 103319.
[13] Hill (2019). ‘Dream come true’: study suggests drug could extend women’s fertility by five years. News Article, Published 22/7/2024.
[14] Effect of Rapamycin in Ovarian Aging (Rapamycin). Clinical Trial, Accessed 24/04/2024. ClinicalTrials.gov ID: NCT05836025
References For Part 3: Fertility Treatment (ART) Interventions:
[15] Mesen, T.B., Mersereau, J.E., Kane, J.B., Steiner, A.Z. (2015). Optimal timing for elective egg freezing. Fertility and Sterility. 103(6):1551-1556.e64.
[16] Armstrong, S., Akande, V. (2013). What is the best treatment option for infertile women aged 40 and over?. Journal of Assisted Reproduction and Genetics. 30(5):667-671.
[17] Chronopoulou, E., Raperport, C., Sfakianakis, A., Srivastava, G., Homburg, R. (2021). Elective oocyte cryopreservation for age-related fertility decline. Journal of Assisted Reproduction and Genetics. 38(5):1177-1186.
[18] Illume Fertility. Understanding Fertility Treatment Costs. Accessed on 06/05/2025.
[19] Smajdor A. (2011). The ethics of IVF over 40. Maturitas. 69(1):37-40.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.